2008 House Bill 6159

Mandate drug company incentive program disclosures

Introduced in the House

May 22, 2008

Introduced by Rep. Mike Simpson (D-65)

To authorize fines of up to $10,000 for a prescription drug manufacturer who fails to comply with the reporting mandate proposed by House Bill 6158, and a $500,000 fine for a firm that intentionally files a false report.

Referred to the Committee on Health Policy